Lasonil Antidolore

Ibuprofen lysine, the active ingredient in Lasonil Antidolore, is a Nonsteroidal anti-inflammatory drug (NSAID) presented as a topical formulation for topical use. It provides relief of mild to moderate musculoskeletal pain and local inflammation in adults.

GNH USA supplies Lasonil Antidolore as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen lysine, an NSAID, reduces inflammation and pain by inhibiting cyclooxygenase enzymes.

- Musculoskeletal pain: alleviates mild to moderate pain associated with strains, sprains, and overuse. - Local inflammation: decreases swelling and discomfort in affected tissues. - Minor injuries: eases pain and inflammation from bruises, cuts, and superficial burns.

Topical ibuprofen lysine may cause local skin reactions, although systemic effects are uncommon.

Common Side Effects: - Skin irritation: mild redness or discomfort at the application site. - Itching: localized pruritus following use. - Burning sensation: transient warmth or stinging. - Dryness: occasional peeling or flaking of the skin.

Serious or Rare Side Effects: - Allergic reactions: angioedema, urticaria, or anaphylaxis. - Severe skin disorders: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Systemic NSAID toxicity: rare gastrointestinal ulceration or renal impairment when large areas are applied.

When using Lasonil Antidolore, consider the following safety measures.

- Assess skin integrity: avoid application on broken, infected, or irritated skin. - Limit exposure: apply only to the recommended surface area and duration. - Check for NSAID allergy: contraindicated in individuals with known hypersensitivity to ibuprofen or other NSAIDs. - Use with caution in pregnancy: consult a healthcare professional before use. - Avoid use in children under 12 years unless directed by a clinician. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Topical ibuprofen lysine can interact with systemic medications; awareness of major and moderate interactions helps minimise risk.

Major Interactions (Avoid): - Concurrent systemic NSAIDs: increased risk of systemic adverse effects. - Anticoagulants (e.g., warfarin, DOACs): heightened bleeding tendency. - Lithium: potential elevation of lithium serum levels.

Moderate Interactions (Monitor Closely): - ACE inhibitors or diuretics: possible impact on renal function. - Corticosteroids: additive risk of gastrointestinal irritation. - Methotrexate: may increase methotrexate toxicity.